Approval · Notice of Compliance 9856 · 2008
LUPRON: Notice of Compliance 9856
Issued October 24, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9856
- Date
- October 24, 2008
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Gonadotropin-releasing hormone analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LUPRON | 00727695 | Cancelled Post Market |
| LUPRON DEPOT | 00884502 | Marketed |
| LUPRON DEPOT | 00836273 | Marketed |
| LUPRON DEPOT | 02148722 | Cancelled Pre Market |
| LUPRON DEPOT | 02148730 | Cancelled Pre Market |
Medicinal ingredients
- LEUPROLIDE ACETATE 5 MG per ML
- LEUPROLIDE ACETATE 3.75 MG per VIAL
- LEUPROLIDE ACETATE 7.5 MG per VIAL
- LEUPROLIDE ACETATE 11.25 MG per VIAL
- LEUPROLIDE ACETATE 15 MG per VIAL